SCHEMBL3617754

SCHEMBL3617754

COc1ccc(Br)c2ccn(S(=O)(=O)c3ccccc3)c12

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 13/20 0.58
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
ALDH1A1 P00352 2/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
FABP4 P15090 1/20 0.39
GAA P10253 1/20 0.39
GFER P55789 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4022373 0.87 HTR6 (0.46) HTR6MEN1KMT2APOLBL3MBTL1
SCHEMBL3622058 0.82 HTR6 (0.55) HTR6MEN1KMT2APOLBL3MBTL1
SCHEMBL3611396 0.81 HTR6 (0.54) HTR6MEN1KMT2APOLBL3MBTL1
SCHEMBL5998134 0.81 HTR6 (0.54) HTR6MEN1KMT2APOLBL3MBTL1
SCHEMBL5998210 0.80 MEN1 (0.54) HTR6MEN1KMT2APOLBL3MBTL1
SCHEMBL930448 0.80 HTR6 (0.53) HTR6MEN1KMT2APOLBL3MBTL1
SCHEMBL3621334 0.78 HTR6 (0.69) HTR6MEN1KMT2APOLBL3MBTL1
SCHEMBL16923796 0.78 HTR6 (0.48) HTR6MEN1KMT2APOLBL3MBTL1
SCHEMBL17857811 0.78 HTR6 (0.54) HTR6MEN1KMT2APOLBL3MBTL1
Trifluoroacetic Acid SCHEMBL4016534 0.77 HTR6 (0.51) HTR6POLBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046741-B1 INDOLES AS 5-HT6 MODULATORS PROXIMAGEN LTD (GB) 2012-10-31 EP disclosed
US-7812017-B2 4-substituted indole and indoline compounds BIOVITRUM AB (PUBL.) (SE) 2010-10-12 US disclosed
EP-2046741-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (publ) (SE) 2009-04-15 EP disclosed
US-20080032968-A1 New compounds PROXIMAGEN NEUROSCIENCE PLC (GB) 2008-02-07 US disclosed
WO-2008003703-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (PUBL) (SE) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080032968-A1 New compounds HTR6, HTR1B, HTR1A HTR6 1/4885MEN1 623/4885KMT2A 3558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.